Neuberger Berman Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $500K | Sell |
|
|||||
|
2024
Q3 | $2.65M | Sell |
|
|||||
|
2024
Q2 | $3.84M | Buy |
|
|||||
|
2024
Q1 | $3.68M | Sell |
|
|||||
|
2023
Q4 | $4.14M | Sell |
|
|||||
|
2023
Q3 | $4.63M | Buy |
|
|||||
|
2023
Q2 | $5.65M | Buy |
|
|||||
|
2023
Q1 | $3.91M | Sell |
|
|||||
|
2022
Q4 | $3.78M | Sell |
|
|||||
|
2022
Q3 | $7.83M | Buy |
|
|||||
|
2022
Q2 | $6.74M | Buy |
|
|||||
|
2022
Q1 | $8.06M | Sell |
|
|||||
|
2021
Q4 | $13.1M | Buy |
|
|||||
|
2021
Q3 | $14.1M | Buy |
|
|||||
|
2021
Q2 | $15.1M | Sell |
|
|||||
|
2021
Q1 | $9.06M | Buy |
|
|||||
|
2020
Q4 | $4.38M | Buy |
|
|||||
|
2020
Q3 | $1.25M | Buy |
|
|||||
|
2020
Q2 | $1.18M | Sell |
|
|||||
|
2020
Q1 | $744K | Buy |
|
|||||
|
2019
Q4 | $864K | Sell |
|
|||||
|
2019
Q3 | $796K | Hold |
|
|||||
|
2019
Q2 | $976K | Buy |
|
|||||
|
2019
Q1 | $922K | Buy |
|
|||||
|
2018
Q4 | $633K | Sell |
|
|||||
|
2018
Q3 | $2.1M | Buy |
|
|||||
|
2018
Q2 | $1.78M | Sell |
|
|||||
|
2018
Q1 | $1.4M | Buy |
|
|||||
|
2017
Q4 | $1.26M | Buy |
|
|||||
|
2017
Q3 | $1.51M | Buy |
|
|||||
|
2017
Q2 | $792K | Buy |
|
|||||
|
2017
Q1 | $607K | Sell |
|
|||||
|
2016
Q4 | $600K | Sell |
|
|||||
|
2016
Q3 | $1.34M | Buy |
|
|||||
|
2016
Q2 | $1.65M | Buy |
|